Cerus Share Price Today
(NASDAQ: CERS)

Name: Cerus Share Price Today (NASDAQ: CERS) - Cerus Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Cerus share price is $1.61 & ₹140.02 as on 6 Mar 2025, 2.30 'hrs' IST

$1.61

▲

0.03

(1.9%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cerus share price in Dollar and Rupees. Guide to invest in Cerus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cerus, along with analyst recommendations, forecasts, and comprehensive financials.

Cerus share price movements

Today's Low: $1.54
Today's High: $1.63
$1.61
4.35%
Downside
Day's Volatility :5.23%
Upside
0.92%
52 Weeks Low: $1.38
52 Weeks High: $2.59
$1.61
14.6%
Downside
52 Weeks Volatility :46.81%
Upside
37.72%

Cerus (CERS) Returns

Period	Cerus Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.47%	3.7%	0.0%
6 Months	-22.6%	-2.8%	0.0%
1 Year	-33.47%	2.5%	0.0%
3 Years	-71.4%	12.9%	-11.6%

Cerus (CERS) Key Statistics

in dollars & INR

Previous Close	$1.58
Open	$1.59
Today's High	$1.625
Today's Low	$1.54
Market Capitalization	$293.5M
Today's Volume	$1.6M
52 Week High	$2.585
52 Week Low	$1.375
Revenue TTM	$180.3M
EBITDA	$-12.4M
Earnings Per Share (EPS)	$-0.11
Profit Margin	-11.6%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.99%

How to invest in Cerus Stock (CERS) from India?

It is very easy for Indian residents to invest directly in Cerus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cerus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cerus or CERS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cerus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cerus shares which would translate to 0.540 fractional shares of Cerus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cerus, in just a few clicks!

Returns in Cerus (CERS) for Indian investors in Rupees

The Cerus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Cerus investment value today

Current value as on today

₹71,478

Returns

₹28,522

(-28.52%)

Returns from Cerus Stock

₹33,471 (-33.47%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cerus (CERS)

-53%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cerus Stock from India on INDmoney has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cerus

ARK Investment Management LLC
11.20%
Baker Bros Advisors LP
10.48%
BlackRock Inc
7.98%
Vanguard Group Inc
5.61%
Wasatch Advisors LP
4.48%
Sumitomo Mitsui Trust Group Inc
3.48%

Analyst Recommendation on Cerus

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Cerus(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cerus Stock (CERS)

What analysts predicted

Upside of 142.24%

Target:

$3.90

Current:

$1.61

Insights on Cerus Stock (Ticker Symbol: CERS)

Price Movement
In the last 3 years, CERS stock has moved down by -70.9%
Increasing Revenue
Revenue is up for the last 4 quarters, 38.36M → 50.80M (in $), with an average increase of 8.8% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -9.68M → -2.52M (in $), with an average increase of 60.3% per quarter
CERS vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 88.8%
CERS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 209.1%
Price to Sales
ForCERS every $1 of sales, investors are willing to pay $1.6, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

Cerus Technicals Summary

Sell

Neutral

Buy

Cerus is currently in a neutral trading position according to technical analysis indicators.

Cerus (CERS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cerus Corp	-13.44%	-22.6%	-33.47%	-71.4%	-67.54%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cerus Corp	NA	NA	0.0	-0.09	-0.38	-0.04	NA	0.3
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cerus Corp	Buy	$293.5M	-67.54%	NA	-11.6%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Cerus

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.

Organization	Cerus
Employees	614
CEO	Mr. William M. Greenman
Industry	Health Technology

Management People of Cerus

Name	Title
Mr. William M. Greenman	President, CEO & Director
Mr. Kevin D. Green CPA	VP of Finance & CFO
Mr. Vivek K. Jayaraman	Chief Operating Officer
Ms. Chrystal Jensen J.D.	Chief Legal Officer & General Counsel
Dr. Richard J. Benjamin MBChB, Ph.D.	Chief Medical Officer
Dr. Laurence M. Corash M.D.	Co-Founder & Chief Scientific Officer
Lainie Corten	Vice President of Global Marketing
Ms. Alicia Goodman	Chief Human Resources Officer
Ms. Carol M. Moore	Senior Vice President of Regulatory Affairs, Quality & Clinical
Dr. Nina Mufti Ph.D.	Senior Vice President of Research & Development

Important FAQs about investing in CERS Stock from India :

What is Cerus share price today?

Cerus share price today stands at $1.61, Open: $1.59 ; Previous Close: $1.58 ; High: $1.63 ; Low: $1.54 ; 52 Week High: $2.59 ; 52 Week Low: $1.38.

The stock opens at $1.59, after a previous close of $1.58. The stock reached a daily high of $1.63 and a low of $1.54, with a 52-week high of $2.59 and a 52-week low of $1.38.

Can Indians buy Cerus shares?

Yes, Indians can invest in the Cerus (CERS) from India.

With INDmoney, you can buy Cerus at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cerus at zero transaction cost.

How can I buy Cerus shares from India?

It is very easy to buy Cerus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cerus (CERS) be purchased?

Yes, you can buy fractional shares of Cerus with INDmoney app.

What are the documents required to start investing in Cerus stocks?

To start investing in Cerus, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.